JUVE Patent

Steven Baldwin is a partner in Kirkland’s IP Litigation Team in London with significant experience representing clients in patent, life sciences regulatory, trade mark, copyright and trade secrets matters. His practice focuses primarily on complex cross-border telecommunications (SEP/FRAND) and life sciences patent disputes, as well as high-profile trade mark and trade secrets cases. Steven frequently plays the role of global coordinating counsel charged with creating and driving forward the client’s litigation strategy across the world.

Steven has been involved in SEP/FRAND litigation in over 30 countries worldwide. Key recent SEP/FRAND cases include, Samsung v ZTE, Panasonic v Xiaomi, Lenovo v Ericsson, MediaTek v Huawei, InterDigital v Lenovo, Sisvel and Mitsubishi v Xiaomi/Oppo, IP Bridge v Huawei (intervening third party), Philips v TCL, and IPCom v Xiaomi (plus numerous other cases that remain confidential). Each of those cases has involved novel aspects of SEP/FRAND law and Steven has been at the very forefront of developing the case law on SEP and FRAND issues in the United Kingdom and beyond. This includes obtaining a ‘first of its kind’ interim licence for Xiaomi from the English Court of Appeal in the Panasonic v Xiaomi case, which has been described as “groundbreaking” and “a spectacular success”.

Steven also regularly acts for the world’s largest pharmaceutical and biosimilar companies and has worked on numerous blockbuster medicines worth billions of dollars worldwide. Example blockbuster biologics and small molecule cases include Pfizer v Amgen, Boehringer v Teva, Regeneron v Kymab and Novartis v MedImmune. Steven also advises on the life sciences regulatory aspects of billion-dollar life sciences deals and has developed a particular interest in, and deep knowledge of, the law governing supplementary protection certificates (SPCs) – he is recognised as a thought leader and regular writer, speaker and commentator on the topic.

Accordingly, Steven’s case experience covers a broad range of technical fields including 3GPP, 3GPP2, IEEE, ITU-T, DMR, TETRA and other wireless (standardised and non-standardised) mobile telecommunications technologies, organic chemistry, antibody biologics, biological product development and screening platforms, formulation science, next generation cancer treatments, and e-cigarette/vaping technologies.

Steven also has significant non-contentious IP experience including billion-dollar IP portfolio purchases, global strategic IP portfolio strategies, and business-critical licensing deals, as well as advising on image rights, sponsorship and global celebrity advertising campaigns for world-renowned soccer clubs and automotive clients.